Letter to the Editor Regarding: Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment
Crossref DOI link: https://doi.org/10.1007/s13300-020-00899-7
Published Online: 2020-08-07
Published Print: 2020-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Iwahori, Toshiyuki http://orcid.org/0000-0001-6972-7900
Funding for this research was provided by:
Eli Lilly Japan
Text and Data Mining valid from 2020-08-07
Version of Record valid from 2020-08-07
Article History
Received: 27 May 2020
First Online: 7 August 2020